These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34955130)

  • 1. [Risk assessment of intensive care unit admission for postoperative patients with stable chronic obstructive pulmonary disease].
    Fan J; Zhao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1209-1214. PubMed ID: 34955130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.
    Song Q; Zhao YY; Zeng YQ; Liu C; Cheng W; Deng MH; Li X; Ma LB; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1401-1412. PubMed ID: 34040367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
    Pandey AK; Verma AK; Singh A; Kant S; Dixit RK; Chaudhary SC; Bajpai J; Prakash V; Verma UP
    Cureus; 2022 Dec; 14(12):e32116. PubMed ID: 36601200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
    Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study.
    Wang Y; Li Z; Li F
    Comb Chem High Throughput Screen; 2023; 26(1):93-102. PubMed ID: 35388750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Clinical Features and Related Factors of Silent Aspiration in Hospitalized COPD Patients.
    Chen S; Hu Y; Zhang W; Liu M
    Altern Ther Health Med; 2022 Oct; 28(7):125-131. PubMed ID: 35951061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
    Ther Adv Respir Dis; 2023; 17():17534666231167353. PubMed ID: 37073797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    PLoS One; 2018; 13(3):e0193880. PubMed ID: 29529075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
    Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
    PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between body composition and disease severity in patients with chronic obstructive pulmonary disease.
    Jin X; Yang Y; Chen G; Shao Y; Liu C; Li R; Liu Y; Zhang L
    Front Med (Lausanne); 2024; 11():1304384. PubMed ID: 38549868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pectoralis muscle area on computed tomography with airflow limitation severity and respiratory outcomes in COPD: A population-based prospective cohort study.
    Zhou K; Wu F; Zhao N; Zheng Y; Deng Z; Yang H; Wen X; Xiao S; Yang C; Chen S; Zhou Y; Ran P;
    Pulmonology; 2023 Mar; ():. PubMed ID: 36907812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.
    Kobayashi S; Hanagama M; Ishida M; Sato H; Ono M; Yamanda S; Yamada M; Aizawa H; Yanai M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3947-3955. PubMed ID: 30584294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.